Literature DB >> 22735765

Transplantation: Tofacitinib safe and effective in renal transplant recipients.

Helene Myrvang.   

Abstract

Entities:  

Year:  2012        PMID： 22735765     DOI： 10.1038/nrneph.2012.120

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year.

Authors:  F Vincenti; H Tedesco Silva; S Busque; P O'Connell; J Friedewald; D Cibrik; K Budde; A Yoshida; S Cohney; W Weimar; Y S Kim; N Lawendy; S-P Lan; E Kudlacz; S Krishnaswami; G Chan
Journal:  Am J Transplant       Date:  2012-06-08       Impact factor: 8.086
  1 in total
  1 in total

Review 1.  Tofacitinab in renal transplantation.

Authors:  Martin S Zand
Journal:  Transplant Rev (Orlando)       Date:  2013-07       Impact factor: 3.943
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.